Skip to content

Clinical trials

Completed Autoimmune Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Status: Completed Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20123
20131
20171
20191
20222
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RemeGen Co., Ltd.2
BeiGene1
Bristol-Myers Squibb1
Changchun GeneScience Pharmaceutical Co., Ltd.1
Erasmus Medical Center1
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1
Huashan Hospital1
Human Genome Sciences Inc., a GSK Company1
Jiangsu HengRui Medicine Co., Ltd.1
Peking University First Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases17
Immune System Diseases3
Diabetes Mellitus2
Diabetes Mellitus, Type 12
Endocrine System Diseases2
Lupus Erythematosus, Systemic2
Metabolic Diseases2
Anti-Glomerular Basement Membrane Disease1
Axial Spondyloarthritis1
Chronic Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.